Successful vismodegib debulking of a giant basal cell carcinoma of the umbilicus

Introduction: Basal cell carcinoma (BCC) of the umbilicus is an exceptional subtype of BCC with potential slowly progressing deeply invasive and wide growth pattern. Vismodegib is a hedgehog pathway inhibitor indicated for the treatment of large, nonoperable or metastatic BCC.

https://ift.tt/2Mi5Huo